AFP/CEA Assay

About MagQu

MagQu is a diagnostics company built on its patented ImmunoMagnetic Reduction (IMR) technology, which enables picoscale, highly sensitive detection of biomarkers in blood. Its core focus is on developing and commercializing assays for Alzheimer's disease (detecting Aβ-40, Aβ-42, and Tau proteins) and cancers like liver and colorectal cancer. The company is commercial-stage, with ISO and GMP certifications, TFDA approvals for its analyzers, and a growing international sales footprint across Asia, Europe, and the US.

Therapeutic Areas